{
    "code": "06012343",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=06012343",
    "time": "2023-06-08 22:26:17",
    "許可證字號": "衛署醫器輸字第012343號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "QSD5514",
    "有效日期": "114\/09\/14",
    "發證\/登錄日期": "94\/09\/14",
    "許可證\/登錄種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00601234306",
    "中文品名": "亞培&quot;設計師&quot; 甲狀腺刺激素檢驗試劑組",
    "英文品名": "ABBOTT ARCHITECT TSH",
    "效能": "變更效能(調整文字敘述)為：本產品以化學冷光微粒免疫分析法(CMIA)定量檢測人類血清及血漿中的人類甲狀腺刺激素(Thyroid Stimulating Hormone, TSH)。",
    "醫器規格": "100Tests\/kit, 400Tests\/kit, 2000Tests\/kit\r\n增加規格及仿單變更：詳如中文仿單核定本（原95年7月25日核定之仿單標籤核定本予以作廢）。以下空白\r\n註銷規格7K62-20及醫療器材規格與標籤、說明書或包裝變更為：詳如醫療器材標籤、說明書或包裝核定本(原104年3月3日醫療器材仿單標籤核定本回收作廢)。以下空白",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "A臨床化學及臨床毒理學用裝置",
    "醫器次類別一": "",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "醫器次類別三": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入",
    "申請商名稱": "美商亞培股份有限公司台灣分公司",
    "申請商地址": "台北市中山區民生東路三段49號5樓、6樓及51號6樓",
    "主製造廠": [
        {
            "製造廠名稱": "ABBOTT IRELAND DIAGNOSTICS DIVISION",
            "製造廠廠址": "LISNAMUCK, LONGFORD, CO. LONGFORD, IRELAND",
            "製造廠公司地址": "",
            "製造廠國別": "IRELAND",
            "製程": ""
        }
    ],
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "06012343-112-04-07.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06012343&Seq=008&Type=9"
        },
        {
            "title": "06012343-112-04-07.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06012343&Seq=005&Type=8"
        }
    ]
}